about
Novel, broad-spectrum anticonvulsants containing a sulfamide group: pharmacological properties of (S)-N-[(6-chloro-2,3-dihydrobenzo[1,4]dioxin-2-yl)methyl]sulfamide (JNJ-26489112)Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disordersInhibitory effects of jujuboside A on EEG and hippocampal glutamate in hyperactive ratLamotrigine increases intracellular Ca(2+) levels and Ca(2+)/calmodulin-dependent kinase II activation in mouse dorsal root ganglion neurones.GABA-ergic drugs: exit stage left, enter stage right.Glutamate drugs and pharmacogenetics of OCD: a pathway-based exploratory approach.The neurobiology of aggression: implications for the pharmacotherapy of aggressive challenging behaviour by people with intellectual disabilities.Painful posttraumatic trigeminal neuropathy: a case report of relief with topiramate.Phenobarbital but Not Diazepam Reduces AMPA/kainate Receptor Mediated Currents and Exerts Opposite Actions on Initial Seizures in the Neonatal Rat Hippocampus.Lipoic acid alters amino acid neurotransmitters content in rat hippocampus after pilocarpine-induced seizures.Unidirectional cross-tolerance from levetiracetam to carbamazepine in amygdala-kindled seizures.SUNCT syndrome successfully treated with topiramate: case reports.A functional magnetic resonance imaging study of cortical asymmetry in bipolar disorder.Loss of hippocampal interneurons and epileptogenesis: a comparison of two animal models of acquired epilepsy.Application of Overexcitation Model Induced by Penicillin Sodium in the Study of Inhibitory Effect of Sedative-Hypnotic Drugs.
P2860
Q30577314-5B082559-DA53-471A-86DB-5E492630DEBFQ33757565-ED06B951-1ED0-4E9B-9F55-4F0CB1CCFEA9Q34425101-ED188472-99A6-4807-8000-BF178160D708Q34507591-B54976AA-479D-4D99-8808-DBA75D811A34Q35180791-AFCB4223-36CE-4E64-9E95-8034743DD969Q38154625-E8819FE9-CF18-4426-B43D-91BD3A6C05A3Q38182182-0E2F0E52-7640-4CAE-A89A-3B2D79F1995AQ39339500-0CC17B01-BEF2-41C4-B76E-E76DFDD7A7F1Q41774263-013EFA3E-D15F-41F2-925F-FFB9F92513ECQ43683034-6ECDFB37-AD06-4FD7-BE7A-5CC896EFB892Q44667872-78C01D7E-0472-4A1B-A830-2B198E43B6B8Q44776570-50FFF647-90E8-4F18-9A5E-033BC3841A57Q45999286-3FE63CC1-A980-4AF4-94AD-0C76EC111CC3Q48956310-0A27BF9A-4D25-4008-A9DE-E86F5AD44A21Q50024371-BE23EACF-8783-48EA-9255-5B79EF224208
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Anticonvulsants: aspects of their mechanisms of action.
@ast
Anticonvulsants: aspects of their mechanisms of action.
@en
Anticonvulsants: aspects of their mechanisms of action.
@nl
type
label
Anticonvulsants: aspects of their mechanisms of action.
@ast
Anticonvulsants: aspects of their mechanisms of action.
@en
Anticonvulsants: aspects of their mechanisms of action.
@nl
prefLabel
Anticonvulsants: aspects of their mechanisms of action.
@ast
Anticonvulsants: aspects of their mechanisms of action.
@en
Anticonvulsants: aspects of their mechanisms of action.
@nl
P2860
P356
P1476
Anticonvulsants: aspects of their mechanisms of action.
@en
P2093
Bo Söderpalm
P2860
P356
10.1053/EUJP.2001.0315
P478
P577
2002-01-01T00:00:00Z